Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients

Jingjing Zhang,Lei Wang,Shasha Zhang,Ruijie Cao,Yufei Zhao,Yue Zhao,Yanrong Song,Zhanjun Guo
DOI: https://doi.org/10.1186/s12885-024-11999-z
IF: 4.638
2024-02-27
BMC Cancer
Abstract:Immune checkpoint inhibitors (ICIs) are commonly used in conjunction with chemotherapy to improve treatment outcomes for patients with gastric cancer. Since AFP could influence immunity by both inhibiting natural killer (NK) cells and regulating negatively the function of dendritic cells, we evaluated the influence of baseline serum alpha-fetoprotein (AFP) levels on the curative effect of ICIs in advanced gastric cancer (AGC) patients.
oncology
What problem does this paper attempt to address?